Olympus America

Press Center

Three New Reagents for Therapeutic Drug Monitoring and Drugs of Abuse Offered in Olympus Bar-Coded Cartridges


Melville, N.Y., March 19, 2004 - Acetaminophen, Salicylic Acid, and Tobramycin assays join the menu of Olympus Therapeutic Drug Monitoring (TDM) and Drugs of Abuse (DAT) reagents available in Olympus bar-coded cartridges. These liquid, ready-to-use formulations provide greater operator convenience and enable automated on-board reagent management.

The full line of reagents features 30-day to 90-day on-board stability with 14-day calibration stability, and are designed for use on Olympus' full line of automated chemistry-immuno analyzers, including the AU400, AU400e, AU600, AU640, AU640e, AU2700 and AU5400 models. The full line of Olympus TDM/DAT reagents includes:

TDMs:
Acetaminophen
Carbamazepine
Digoxin
Gentamicin
NAPA
Phenobarbital
Phenytoin
Procainamide
Quinidine
Salicylic Acid
Theophylline
Tobramycin
Valproic Acid
DATs:
Barbiturate
Benzodiazepine
Cannabinoid
Cocaine Metabolite
Ethanol
Methadone
Methaqualone
Opiates
Phencyclidine
Propoxyphene

Click here for additional information about Olympus reagents or call the Olympus Diagnostic Systems Group at 800-223-0125 extension 5654.

About Olympus Diagnostic Systems Group
Since 1981, Olympus Diagnostic Systems Group has provided innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks and pharmaceutical labs. Offering the broadest standardized line of random access, chemistry-immuno analyzers and lab automation systems, Olympus' solutions save laboratories time, maximize productivity and deliver fast, reliable results.

About Olympus
Olympus is a precision technology leader, designing and delivering innovative solutions in healthcare and consumer electronics worldwide.

Olympus works collaboratively with its customers and its parent company, Tokyo-based Olympus Corporation, to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced clinical and research microscopes;
  • Lab automation systems, chemistry-immuno and blood bank analyzers and reagents; and
  • Digital and film cameras, and digital voice recorders.
  • In the U. S. and Canada, Olympus serves healthcare, scientific and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers efficiently, reliably, safely, and easily achieve superior results. Olympus is the leader in gastrointestinal endoscopy and clinical and educational microscopes. The company's market-leading consumer electronics business spans North and South America. For more information, visit www.olympusamerica.com.